We thus undertook a randomized cross-over clinical trial with high-risk individuals participating in a lung cancer screening study for people who had smoked or were still smoking with plasma CRP >2 mg/L to determine the effect of EPA + DHA natural product supplements on the levels of inflammatory markers. This evidence concerns the gene CRP and lung carcinoma.